Michael Caruana

4.6k total citations · 1 hit paper
54 papers, 1.5k citations indexed

About

Michael Caruana is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Michael Caruana has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 18 papers in Surgery and 16 papers in Epidemiology. Recurrent topics in Michael Caruana's work include Global Cancer Incidence and Screening (20 papers), Colorectal Cancer Screening and Detection (15 papers) and Cervical Cancer and HPV Research (12 papers). Michael Caruana is often cited by papers focused on Global Cancer Incidence and Screening (20 papers), Colorectal Cancer Screening and Detection (15 papers) and Cervical Cancer and HPV Research (12 papers). Michael Caruana collaborates with scholars based in Australia, United Kingdom and Canada. Michael Caruana's co-authors include Karen Canfell, Jie‐Bin Lew, Kate T. Simms, Thierry Lévy, Megan A. Smith, Terry Lyons, Philip E. Castle, Julia Steinberg, Isabelle Soerjomataram and Freddie Bray and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Michael Caruana

49 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study

2019 326 citations Kate T. Simms, Julia Steinberg et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Michael Caruana

Since Specialization

Citations

This map shows the geographic impact of Michael Caruana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Caruana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Caruana more than expected).

Fields of papers citing papers by Michael Caruana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Caruana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Caruana. The network helps show where Michael Caruana may publish in the future.

Co-authorship network of co-authors of Michael Caruana

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Caruana. A scholar is included among the top collaborators of Michael Caruana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Caruana. Michael Caruana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010–2070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening 2025 ·Vaccine ·(unknown), Michaela Hall, Michael Caruana, (unknown), Louiza S. Velentzis, Megan A. Smith, C. David Wrede, Deborah Bateson, Karen Canfell	1
2	Using Bayesian evidence synthesis to quantify uncertainty in population trends in smoking behaviour 2025 ·Statistical Methods in Medical Research ·Stephen Wade, Peter Sarich, Pavla Vaneckova, S. Behar Harpaz, (unknown), Paul Grogan, Sonya Cressman, Coral Gartner, John M. Murray, Tony Blakely, Emily Banks, Martin C. Tammemägi, Karen Canfell, Marianne Weber, Michael Caruana	2
3	Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations 2025 ·Medical Decision Making ·Joachim Worthington, Eleonora Feletto, Emily He, Stephen Wade, Barbara de Graaff, Anh Tuan Nguyen, Jacob George, Karen Canfell, Michael Caruana	0
4	A Health Economic Evaluation of Routine Hepatocellular Carcinoma Surveillance for People with Compensated Cirrhosis to Support Australian Clinical Guidelines 2025 ·MDM Policy & Practice ·Joachim Worthington, Emily He, Michael Caruana, Stephen Wade, Barbara de Graaff, Anh Tuan Nguyen, Jacob George, Karen Canfell, Eleonora Feletto	0
5	Recalibrating an Established Microsimulation Model to Capture Trends and Projections of Colorectal Cancer Incidence and Mortality 2025 ·Medical Decision Making ·Jie‐Bin Lew, Qingwei Luo, Joachim Worthington, Han Ge, Emily He, Julia Steinberg, Michael Caruana, Dianne L. O’Connell, Eleonora Feletto, Karen Canfell	2
6	Estimates of the eligible population for Australia’s targeted National Lung Cancer Screening Program, 2025–2030 2024 ·Public Health Research & Practice ·Stephen Wade, (unknown), (unknown), Michael Caruana, Julia Steinberg, Qingwei Luo, Michael David, Annette McWilliams, Kwun M. Fong, Karen Canfell, Marianne Weber	3
7	Trends and projections of cause-specific premature mortality in Australia to 2044: a statistical modelling study 2024 ·The Lancet Regional Health - Western Pacific ·Qingwei Luo, Julia Steinberg, Clare Kahn, Michael Caruana, Paul Grogan, Andrew Page, Rebecca Ivers, Emily Banks, Dianne L. O’Connell, Karen Canfell	0
8	Public Preferences for Genetic and Genomic Risk-Informed Chronic Disease Screening and Early Detection: A Systematic Review of Discrete Choice Experiments 2024 ·Applied Health Economics and Health Policy ·(unknown), (unknown), Richard Norman, Amelia K. Smit, Anne Ε. Cust, (unknown), Michael Caruana, Louisa G. Gordon, Karen Canfell, Julia Steinberg, Alison Pearce	3
9	Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040 2022 ·Scientific Reports ·Qingwei Luo, Jie‐Bin Lew, Julia Steinberg, Joachim Worthington, Xue Qin Yu, Michael Caruana, Isabelle Soerjomataram, Freddie Bray, (unknown), (unknown), Dianne L. O’Connell, Karen Canfell, Eleonora Feletto	10
10	How Well Have Projected Lung Cancer Rates Predicted the Actual Observed Rates? 2021 ·Asian Pacific Journal of Cancer Prevention ·Qingwei Luo, Julia Steinberg, Xue Qin Yu, Michael Caruana, Karen Canfell, (unknown)	2
11	Impact of Scaled up Human Papillomavirus Vaccination and Cervical Screening and the Potential for Global Elimination of Cervical Cancer in 181 Countries, 2020–99: A Modelling Study 2019 ·Obstetrical & Gynecological Survey ·Kate T. Simms, Julia Steinberg, Michael Caruana, Megan A. Smith, Jie‐Bin Lew, Isabelle Soerjomataram, Philip E. Castle, Freddie Bray, Karen Canfell	16
12	Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study breakdown → 2019 ·The Lancet Oncology ·Kate T. Simms, Julia Steinberg, Michael Caruana, Megan A. Smith, Jie‐Bin Lew, Isabelle Soerjomataram, Philip E. Castle, Freddie Bray, Karen Canfell	326
13	Statistical projection methods for lung cancer incidence and mortality: a systematic review 2019 ·BMJ Open ·Xue Qin Yu, Qingwei Luo, Suzanne Hughes, Stephen Wade, Michael Caruana, Karen Canfell, Dianne L. O’Connell	25
14	Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates 2019 ·Public Health Research & Practice ·Jie‐Bin Lew, Eleonora Feletto, Stephen Wade, Michael Caruana, Yoon‐Jung Kang, Carolyn Nickson, Kate T. Simms, P. Procopio, Natalie Taylor, Joachim Worthington, David Smith, Karen Canfell	34
15	Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia 2018 ·BMJ Open ·Karen Canfell, Marion Saville, Michael Caruana, Val Gebski, (unknown), Julia Brotherton, Stella Heley, Philip E. Castle	25
16	Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study 2018 ·Scientific Reports ·Visalini Nair‐Shalliker, (unknown), Marianne Weber, David Goldsbury, Michael Caruana, Jon Emery, Emily Banks, Karen Canfell, Dianne L. O’Connell, David P. Smith	15
17	Lung cancer mortality in Australia: Projected outcomes to 2040 2018 ·Lung Cancer ·Qingwei Luo, Xue Qin Yu, Stephen Wade, Michael Caruana, Francesca Pesola, Karen Canfell, Dianne L. O’Connell	22
18	Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial 2017 ·PLoS Medicine ·Karen Canfell, Michael Caruana, Val Gebski, (unknown), Stella Heley, Julia Brotherton, Dorota M. Gertig, (unknown), Annabelle Farnsworth, Jeffrey Tan, C. David Wrede, Philip E. Castle, Marion Saville	62
19	ESTIMATING THE BENEFITS AND HARMS OF PSA TESTING IN THE AUSTRALIAN CONTEXT 2014 ·Griffith Research Online (Griffith University, Queensland, Australia) ·Michael Caruana, Yoon‐Jung Kang, David P. Smith, Dianne L. O’Connell, Karen Canfell	1
20	Peano's theorem for rough differential equations in infinite-dimensional Banach spaces 2009 ·Proceedings of the London Mathematical Society ·Michael Caruana	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact